IGF-1 lab test: what the number means

IGF-1 is not a direct measure of growth hormone — it’s a downstream signal that reflects how active the GH axis has been over the preceding days. Understanding the distinction matters when interpreting your result.

TL;DR

• IGF-1 (insulin-like growth factor 1) is produced primarily in the liver in response to GH signaling — it’s a surrogate marker, not GH itself.
• Reference ranges are tightly age- and sex-adjusted: a level that’s mid-range for a 30-year-old is elevated for a 60-year-old.
• Clinicians use IGF-1 to guide dosing decisions in GH-secretagogue protocols and to monitor for supraphysiological elevation.

What it is

IGF-1 is a peptide hormone produced primarily in the liver. It is released in response to growth hormone (GH) signaling from the pituitary and mediates many of GH’s downstream effects — including protein synthesis, cellular growth, and metabolic regulation. Because GH itself has a pulsatile secretion pattern (levels fluctuate significantly hour-to-hour), a random serum GH measurement is not clinically useful. IGF-1 has a longer half-life and more stable serum concentration, making it a reliable integrated measure of recent GH-axis activity. The Endocrine Society uses serum IGF-1 as the primary biochemical tool for both diagnosing adult GH deficiency and monitoring GH-axis therapy (Endocrine Society, 2019).

How it works

IGF-1 levels are reported in ng/mL and are compared against age- and sex-specific reference ranges derived from large population studies. LabCorp and Quest Diagnostics publish laboratory-specific reference intervals; clinicians use the range corresponding to the patient’s age and sex at the time of the draw. The chart below shows the general shape of the IGF-1 age-decline curve across a male lifespan, based on published population norms.

Who asks about it

People who’ve received their IGF-1 result from a standard lab draw often have two questions: is this number high or low, and what does it mean for their protocol? The answer to both requires knowing the age-adjusted reference range, which most lab reports include but many patients don’t know how to read.

What the research says

Elevated IGF-1 — specifically levels sustained above the age-adjusted upper limit of normal — is associated with the condition of acromegaly when caused by a GH-secreting pituitary tumor. Physiological elevation from a GH-secretagogue protocol does not carry the same pathological implications, but clinicians monitor IGF-1 precisely to ensure levels do not exceed the normal range for age (Katznelson et al., Endocrine Society Clinical Practice Guideline for Acromegaly, 2014). Age-specific normal ranges for IGF-1 are published by both LabCorp and Quest Diagnostics and are the reference used in clinical interpretation.

What to know before considering it

IGF-1 interpretation requires clinical context: the same number can be appropriate or concerning depending on your age, sex, baseline, and current protocol. A number at the top of the normal range may prompt a prescriber to adjust dosing; a number modestly below the lower limit may confirm the rationale for a GH-secretagogue protocol. Neither interpretation is something to reach for without a clinician’s guidance.

The Halftime POV

The IGF-1 test is one of the more informative single biomarkers in a preventive health panel — it provides a window into GH-axis function that most standard annual physicals don’t include. For patients on protocols that affect the GH axis, having a documented baseline and consistent follow-up cadence is what separates a well-managed protocol from a poorly monitored one.

Related reading:

• Biomarkers For Peptide Protocols
• Sermorelin Explained
• Cjc 1295 Ipamorelin Combination

FAQ

Q: What does an IGF-1 lab test measure? A: IGF-1 (insulin-like growth factor 1) is produced primarily by the liver in response to growth hormone signaling. Because GH itself has a short half-life and is released in pulses, IGF-1 is used as a more stable, measurable proxy for GH-axis activity. A single blood draw for IGF-1 reflects GH activity over the preceding days rather than at a single moment.

Q: What are normal IGF-1 reference ranges? A: IGF-1 reference ranges are age-adjusted — they vary significantly across the lifespan. Peak values are typically in early adulthood (approximately 180–300 ng/mL for adults in their 20s, depending on the lab). Values decline with age: clinicians typically compare a patient’s IGF-1 to the reference range for their specific age group, not a single universal range.

Q: What does a low IGF-1 mean? A: Low IGF-1 relative to age-adjusted reference ranges may indicate reduced GH-axis activity — one component of somatopause. It can also reflect nutritional status, liver function, or hypothyroidism, which is why a complete metabolic context is important before attributing low IGF-1 solely to GH decline. The interpretation requires a clinician’s assessment of the full lab picture.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.

Sources

• Yuen KCJ et al., “American Association of Clinical Endocrinologists Guidelines for Management of Growth Hormone Deficiency in Adults” — Endocrine Practice, 2019
• Katznelson L et al., “Acromegaly: An Endocrine Society Clinical Practice Guideline” — JCEM, 2014
• IGF-1 Reference Intervals — LabCorp Test Menu

This article discusses compounds that are currently under FDA Category 2 review (see our FDA categorization explainer). These compounds are not currently part of Halftime Health’s published protocol catalog. This article is provided for educational purposes only and does not constitute medical advice or an offer to sell.